Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108059666A reveals solid-liquid combination for Semaglutide. Reduces synthesis steps, improves purity, and offers cost reduction in API manufacturing for global supply chains.
Patent CN117946130A reveals a novel cinchona-catalyzed route for chiral spiro indolinone derivatives, offering significant cost reduction and supply chain reliability for anti-tumor drug manufacturing.
Patent CN114075153A details a high-yield, two-step Pd-catalyzed route for Vortioxetine impurity reference standards, ensuring superior purity and supply chain stability.
Patent CN114591303B details a novel synthesis for high-purity COVID-19 drug intermediates, offering improved yield and superior solid-state properties for reliable pharmaceutical manufacturing.
Patent CN112457263A details a metal-free, water-based synthesis of aryl sulfone derivatives, offering significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN104177394B reveals a cost-effective Entecavir intermediate route with mild conditions, offering supply chain stability and high purity for antiviral drug production.
Patent CN110878055B details a green synthesis route for benzimidazolones using atmospheric CO2, offering significant cost reduction and safety advantages for pharmaceutical manufacturing.
Patent CN100368388C details a novel Knoevenagel synthesis for cyano-substituted resveratrol analogues, offering enhanced antitumor activity and scalable production for pharmaceutical intermediates.
Patent CN102351849B reveals a novel one-pot synthesis for Olmesartan Medoxomil intermediates, offering high purity, reduced operational complexity, and scalable manufacturing solutions.
Patent CN111479800B reveals solid-phase synthesis for kappa opioid agonists. Offers high purity and scalable production for reliable pharmaceutical intermediate supply chains.
Patent CN102162002B details an enzymatic route for cyclohexenone derivatives. Mild conditions, high yield, and eco-friendly processing for pharmaceutical intermediates.
Patent CN108299429B details a novel synthesis for octahydrobenzonaphthyridine compounds with enhanced antitumor activity and solubility, offering significant cost reduction in API manufacturing.
Patent CN105985990B details a green enzymatic route for phenylephrine intermediates using KRED and antioxidants, offering significant cost reduction in API manufacturing.
Novel process for pyrido-benzazepine intermediates via glutaraldehyde cyclization. Enhances purity and scalability for ACE inhibitor production.
Advanced synthesis of (E)2-(2-(9-alkyl)carbazole-3-)vinyl-benzimidazole via POCl3 cyclization. Reliable supplier offering cost-effective, scalable manufacturing solutions.
Advanced synthesis of Chenodeoxycholic Acid via hypochlorite oxidation. High yield, low cost route for API manufacturing. Reliable pharmaceutical intermediates supplier.
Novel two-step process avoids acid chlorides. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112479948A details a novel NHC-catalyzed asymmetric Michael addition for beta-sulfonyl chiral amines, offering metal-free synthesis and high enantioselectivity for pharmaceutical intermediates.
Patent CN108586283A enables visible-light synthesis of alpha-azide ketones using air oxidant. Reduces metal waste and offers cost-effective pharmaceutical intermediate manufacturing solutions.
Novel visible-light method for isoquinoline derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.